Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Observational Study in Naturalistic Settings to Describe Long Acting Buprenorphine Introduction in France: Change in Severity of Addiction and Health Related Quality of Life Over a Period of 6 Months.

NCT06266039 is registered in ClinicalTrials.gov with University of Bordeaux as lead sponsor.

NCT NCT06266039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06266039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Observational Study in Naturalistic Settings to Describe Long Acting Buprenorphine Introduction in France: Change in Severity of Addiction and Health Related Quality of Life Over a Period of 6 Months.
Lead sponsor
University of Bordeaux
Phase
Observational
Overall status
Unknown status
Start date
March 31, 2023
Completion date
September 30, 2024
Enrollment
223 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

addiction opiate